REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- CollPlant (Nasdaq:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, is pleased to issue the following letter from its Chief Executive Officer, Yehiel Tal, to its shareholders.
Read more at prnewswire.comCollPlant Issues Letter to Shareholders
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here